Lynne Marie Sullivan

This profile gathers the share dealings of Lynne Marie Sullivan across 2 companies, led by Unity Biotechnology, Inc. and BiomX Inc. We count 11 filings; the first trade dates from 13 September 2020 and the latest from 2 April 2025.

Both buying and selling appear: 1 purchase worth €42k, against 5 sales worth €22k. On balance, insiders were net buyers of €20k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 4 share grants. So far in 2025, the count stands at no purchases and 2 sales.

The record was last updated on 3 April 2025 with an open-market sale (€21k) in Unity Biotechnology, Inc. The clock since the last published purchase (30 July 2021) now reads 1,927 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.